Module232025

12/05/2025

• Increase awareness of the FAIR trial principles with key stakeholders in early drug development • Repeat the survey every 3 years to identify practise changes with indicators • In the process of analyzing/publishing on the trends in the following areas in relevance to cancer AYA inclusion • PIPs • Clinical trial • Labelling FAIR ongoing work

The Organisation for Professionals in Regulatory Affairs

53

Be ready to be the generation of regulatory professionals that will challenge dogmas!

The Organisation for Professionals in Regulatory Affairs

54